Get started
Author

Concha Amador

Observed names: C. Amador, Concepcion Amador, Concepción Amador
ORCID: 0000-0003-0843-8624
Observed ORCID: 0000-0003-0843-8624
OpenAlex ID: A5042644349
Risk Factors for Acquisition of Urinary Tract Infections Caused by Ciprofloxacin Resistant Escherichia Coli
1995 · Javier Ena, Concepcion Amador, et al. · The Journal of Urology · 118
Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region
2005 · F. Pasquau, J. Ena, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 102
Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli
2006 · Javier Ena, Francisco Arjona, et al. · Urology · 97
Increasing Incidence of Hepatocellular Carcinoma in HIV-Infected Patients in Spain
2012 · Nicolás Merchante, Esperanza Merino, et al. · Clinical Infectious Diseases · 75
Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study
2020 · Sergio Serrano-Villar, Javier Martínez-Sanz, et al. · The Lancet HIV · 62
Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events
2023 · Javier Martínez-Sanz, Jorge Díaz-Álvarez, et al. · EBioMedicine · 57
PDF
Pneumonia Due to Bordetella bronchiseptica in a Patient with AIDS
1991 · C. Amador, E. Chiner, et al. · Clinical Infectious Diseases · 50
Risk and determinants of developing severe liver toxicity during therapy with nevirapine-and efavirenz-containing regimens in HIV-infected patients
2003 · Javier Ena, Concepción Amador, et al. · International Journal of STD & AIDS · 49
Once-a-Month Administration of Intravenous Pentamidine to Patients Infected with Human Immunodeficiency Virus as Prophylaxis for Pneumocystis carinii Pneumonia
1994 · J. Ena, C. Amador, et al. · Clinical Infectious Diseases · 35
Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial
2025 · Pablo Ryan, José L Blanco, et al. · The Lancet HIV · 34
Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice
2023 · Inés Suárez-García, Belén Alejos, et al. · Journal of Antimicrobial Chemotherapy · 34
PDF
Eruptive Melanocytic Nevi in Human Immunodeficiency Virus Infection
1991 · Isabel Betlloch, Concepción Amador, et al. · International Journal of Dermatology · 32
Chagas disease screening in pregnant Latin American women: Adherence to a systematic screening protocol in a non-endemic country
2021 · Jara Llenas-García, Philip Wikman-Jorgensen, et al. · PLoS neglected tropical diseases · 27
Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015
2016 · José Antonio Iribarren, Rafael Rubio, et al. · Enfermedades Infecciosas y Microbiología Clínica · 20
PDF
Multicenter epidemiological and clinical study on imported Chagas diseases in Alicante, Spain
2012 · José M Ramos, Diego Torrús, et al. · Pathogens and Global Health · 20
Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015
2016 · José Antonio Iribarren, Rafael Rubio, et al. · Enfermedades Infecciosas y Microbiología Clínica · 17
Prevalence of non-alcoholic fatty liver disease in a multicentre cohort of people living with HIV in Spain.
2023 · Jordi Navarro, Adrian Curran, et al. · European Journal of Internal Medicine · 15
Erythema Annular Centrifugum in Q Fever
1991 · Isabel Betlloch, Concepción Amador, et al. · International Journal of Dermatology · 15
Pharmacological and clinical evidence of nevirapine immediate- and extended-release formulations
2012 · Javier Ena, Concepcion Amador, et al. · HIV/AIDS - Research and Palliative Care · 14
PDF
Net benefits of resistance testing directed therapy compared with standard of care in HIV-infected patients with virological failure: A meta-analysis
2006 · Javier Ena, Rosa F. Ruiz de Apodaca, et al. · Enfermedades Infecciosas y Microbiología Clínica · 14
Distribución anormal de la grasa corporal y tipo de tratamiento antirretroviral como predictores de riesgo de enfermedad cardiovascular en pacientes infectados por el virus de la inmunodeficiencia humana
2004 · Javier Ena, Concepción Benito, et al. · Medicina Clínica · 14
Ciprofloxacin as an effective antibacterial agent in serratia endocarditis
1991 · J. Ena, C. Amador, et al. · Journal of Infection · 12
Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection
2021 · M. Masiá, S. Padilla, et al. · Trials · 10
PDF
Factores de riesgo asociados a la aparición de infecciones durante el primer año de tratamiento antirretroviral de alta eficacia
2001 · Concepción Amador, Vicente Bodi, et al. · Medicina Clínica · 10
Physicians’ opinions on generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection: a multicentre survey in Spain
2019 · Inés Suárez-García, Marta Ruiz-Algueró, et al. · Journal of Antimicrobial Chemotherapy · 9
Works count: 41
Citation count: 1,053
H-index: 17
I10-index: 25
Year
Topic
Type